Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06585670 · ClinicalTrials.gov registry record · NA

Mindfulness Approach for Reducing Anxiety and Gloom in Ocular Inflammatory Diseases

A NA study of Non-infectious Uveitis, sponsored by University of California, San Francisco.

Active
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06585670: Active NA study of Non-infectious Uveitis, sponsored by University of California, San Francisco.

NCT06585670 is a NA study of Non-infectious Uveitis that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06585670, a NA study of Non-infectious Uveitis, is active but no longer recruiting, sponsored by University of California, San Francisco.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The proposed study is a block-randomized, controlled trial to evaluate the effects of a digital meditation and mindfulness practice on mental health in patients with non-infectious uveitis.

Primary Outcome

The severity of anxiety symptoms of participants will be assessed by the 7-item Generalized Anxiety Disorder (GAD-7) questionnaire, which is a diagnostic self-report scale that can be used to screen for and assess the severity of Generalized Anxiety Disorder (GAD). The questionnaire asks the participant to self-report the frequency of 7 different anxiety symptoms on a scale of 0 (not at all) to 3 (nearly every day) over the past two weeks. Scores ranging from 0-4 represent none to minimal anxiet

Conditions Studied

Interventions

  • OTHER Calm Health - smartphone application

Study Locations (1)

California

  • UCSF - San Francisco

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-08-26
Est. Completion 2025-08
Phase NA

What the registry record for NCT06585670 still lists

NCT06585670 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Non-infectious Uveitis appearing as the primary indexed condition, and to 1 intervention - of which Calm Health - smartphone application is the first listed.

NCT06585670 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06585670 about?

NCT06585670 is a clinical study titled "Mindfulness Approach for Reducing Anxiety and Gloom in Ocular Inflammatory Diseases". The proposed study is a block-randomized, controlled trial to evaluate the effects of a digital meditation and mindfulness practice on mental health in patients with non-infectious uveitis.

What is the current status of trial NCT06585670?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-08-26. Estimated completion is 2025-08.

What conditions does trial NCT06585670 study?

This clinical trial studies the following conditions: Non-infectious Uveitis.

What interventions are being tested in trial NCT06585670?

The interventions under investigation include: Calm Health - smartphone application (OTHER).

Who is sponsoring clinical trial NCT06585670?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06585670 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Non-infectious Uveitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06585670's enrollment target sits among peer trials

100 840th of 2000 higher than 1,081 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06585670, the US trial registry maintained by the National Library of Medicine. NCT06585670 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.